Home All Products Tesamorelin Injection 2 Mg

Tesamorelin Injection 2 Mg

$70

Tesamorelin Injection 2 Mg is a synthetic peptide designed to stimulate the natural release of growth hormone by acting on the pituitary gland. It is structurally similar to growth hormone–releasing hormone (GHRH) and is widely recognized in clRead More



Product Specifications
  • Strength:

    2 Mg

  • Active Ingredient:

    Tesamorelin Acetate

  • Drug Class:

    Growth Hormone Releasing Hormone Analogue

  • Product Type:

    Injectable Peptide

Description

Product Description

Tesamorelin Injection 2 Mg is a synthetic peptide designed to stimulate the natural release of growth hormone by acting on the pituitary gland. It is structurally similar to growth hormone–releasing hormone (GHRH) and is widely recognized in clinical and research settings for its targeted action on growth hormone regulation. This injectable formulation is known for supporting metabolic balance and body composition by promoting the body’s own physiological pathways rather than supplying external hormones. Tesamorelin is commonly associated with applications related to fat metabolism, particularly in managing excess visceral fat, while helping preserve lean muscle mass.


Key Features



  • High-purity synthetic peptide (GHRH analogue)

  • Supports natural growth hormone secretion

  • Targeted action with minimal systemic impact

  • Supplied in lyophilized (freeze-dried) powder form for stability

  • Intended for professional, clinical, or research use

Product Specifications
Strength 2 mg
Active Ingredient Tesamorelin acetate
Drug Class Growth hormone releasing hormone analogue
Product Type Injectable peptide
Molecular Weight 5135 Da
Primary Function Stimulates HGH secretion
Mechanism Activates GHRH receptors
Target System Endocrine system
Administration Subcutaneous injection
Dosage Form Injectable solution
Frequency Daily injection
Formulation Prefilled syringe or vial
Storage 2–8°C
Shelf Life 24 months
Packaging Sterile injection vial
Appearance Clear or lyophilized powder
Stability Sensitive to heat
Application Clinical therapy
Country Of Origin Canada
Product Specifications
Strength 2 mg
Active Ingredient Tesamorelin acetate
Drug Class Growth hormone releasing hormone analogue
Product Type Injectable peptide
Molecular Weight 5135 Da
Primary Function Stimulates HGH secretion
Mechanism Activates GHRH receptors
Target System Endocrine system
Administration Subcutaneous injection
Dosage Form Injectable solution
Frequency Daily injection
Formulation Prefilled syringe or vial
Storage 2–8°C
Shelf Life 24 months
Packaging Sterile injection vial
Appearance Clear or lyophilized powder
Stability Sensitive to heat
Application Clinical therapy
Country Of Origin Canada
Home
All Products
Search
Contact